Releaf
Releaf is a UK-headquartered digital medical cannabis clinic operating in the United Kingdom and Germany, serving over 200,000 patients with online consultations, AI-assisted strain matching, prescription issuance, and pharmacy-fulfilled delivery of medical cannabis flower.
- Company typePrivate
- Founded2022
- HeadquartersLondon, United Kingdom
- Headcount101–250
- GTM typeB2C
- OfferingServices
What Releaf does
Releaf is a private, UK-headquartered digital medical cannabis clinic group operating in the United Kingdom and Germany under the entities Releaf Dispensary Ltd and Releaf DE GmbH (Neuss). The company delivers an end-to-end telemedicine workflow: patients select products from a curated 50+ strain catalogue, complete a 15-question medical questionnaire without a required video consultation, receive physician review and prescription issuance, and have medication dispatched by licensed partner pharmacies (Grafenberger Apotheke in Düsseldorf, Apotheke am Bahnhof in Speyer) with same-day courier in seven major German cities and 1–3 day standard delivery elsewhere. Its platform is differentiated by an AI-powered strain search tool, ISO 27001 and ISO 9001 certifications, and a no-subscription, no-monthly-fee pricing model (€5.99 prescription fee plus per-gram product pricing in Germany; UK private clinic pricing not publicly disclosed).
Releaf's business model is fee-for-service and direct-to-consumer e-commerce. In Germany, the company monetises per prescription plus per-gram flower sales, with checkout supporting Klarna, Apple Pay, Google Pay, Visa, Mastercard, Amex, PayPal, and SEPA. In the UK, it operates a private clinic serving 220,000+ patients cumulatively, complemented by ancillary services such as the 2026-launched Releaf Protect 24/7 legal support offering in partnership with UK law firm Irwin Mitchell and the Releaf Cannabis Card for portable prescription verification. The customer base is diversified across multiple therapeutic verticals — chronic pain (73% of prescriptions, the primary use case), mental health, sleep disorders, neurology, gynecology, gastroenterology, and oncology — and the company maintains an active content, SEO, paid media, and PR engine to sustain patient acquisition.
The company was founded in 2022, expanded into Germany in 2024 following Germany's CanG reform, and raised a $6.75M funding round in 2024. It employs 101–250 staff across medical, executive, patient support, triage, marketing, finance, and HR functions, with a named C-suite (CEO Tim Kirby, CTO Oliver Soar, CFO Scott Stephen, COO Graham Woodward, CLO Rupa Shah) and a Medical Director. Partnerships span product supply (Aurora via the Pedanios line, Cannamedical), pharmacy dispensing (Grafenberger Apotheke, Apotheke am Bahnhof), and patient legal services (Irwin Mitchell). Ownership composition, founder equity, and detailed financials are not disclosed in the source material.
Releaf firmographics
Firmographics- Name
- Releaf
- Legal name
- Releaf DE GmbH
- Website
- https://releaf.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Releaf is a UK-headquartered digital medical cannabis clinic operating in the United Kingdom and Germany, serving over 200,000 patients with online consultations, AI-assisted strain matching, prescription issuance, and pharmacy-fulfilled delivery of medical cannabis flower.
- Ownership category
- akta.pro rank
Releaf industry classification
Industry- Product category
- Medical Cannabis Telehealth
- NAICS
- Medical and Diagnostic Laboratories (6215)
- SIC
- Retail-Drug Stores And Proprietary Stores (5912)
- akta.pro primary industry
- Medical Cannabis Dispensaries (CRANAFAB)
- akta.pro secondary industry
- Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail) (CRANAFAG)
Keywords
Where Releaf is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices4 records
Markets served
Releaf business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain, Infrastructure
Revenue model
- Prescription fee + product sales (Germany): Patients pay a flat €5.99 per prescription (Rx fee) plus per-gram product pricing (e.g., 10g packs ranging from ~€47 to ~€121) for medical cannabis flower, fulfilled via partner German pharmacies. No subscriptions, no monthly fees, no minimum terms.
- Direct medical cannabis e-commerce: Releaf's own e-commerce storefront enables direct unit-priced purchases of medical cannabis, with checkout supported by Klarna, Apple Pay, Google Pay, Visa, Mastercard, Amex, PayPal and SEPA.
- Private medical cannabis clinic services (UK): Fee-for-service private clinic revenue from over 220,000 UK patients accessing digital consultations, prescriptions and medication, with structured patient pathways and additional services such as the "Releaf Protect" 24/7 legal support service.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Flat €5.99 prescription fee + per-gram product pricing in Germany |
| Other | Pay-as-you-go | Private UK clinic pricing not publicly disclosed in source |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels8 records
Releaf product offering
Product offeringCore offering
Releaf is a private medical cannabis clinic group operating in the UK and Germany that delivers online specialist consultations, physician-issued prescriptions, and direct-to-patient pharmacy fulfillment of 50+ medical cannabis flower strains via a proprietary digital health platform with AI-assisted strain matching. Patients complete a 15-question medical questionnaire (no video call required), receive a prescription (€5.99 flat fee in Germany) and have medication delivered same-day or next-day from licensed partner pharmacies, with the UK parent entity being Releaf Dispensary Ltd and the German subsidiary being Releaf DE GmbH.
Product overview
Releaf operates a single unified telehealth/mail-order medical cannabis clinic platform with country-specific localisations rather than a distinct platform-plus-modules architecture. The core service — Releaf UK — provides online specialist consultations, prescriptions, and direct-to-patient dispensing of medical cannabis, supported by the AI-powered cannabis strain search and the Releaf Cannabis Card (proof of legal entitlement). Releaf Germany (Releaf DE) is the country-specific localisation of the same core clinic service for the German market, sharing the core prescribing and fulfilment flow. Releaf Protect is an add-on legal-support service offered to patients in partnership with the law firm Irwin Mitchell. Together, the UK and DE services form the core product, while the AI strain search, Cannabis Card, and Releaf Protect function as integrated features/add-on offerings within the same patient journey.
Differentiator
Problem solved
Functional benefit
Brands
- Releaf Protect: 24/7 patient legal support service operated by Releaf in partnership with UK law firm Irwin Mitchell, launched in 2026.
Quantifiable outcome
- 97% of 1,669 surveyed patients reported improved quality of life with cannabis treatment (2025 UK survey)
- +5 more outcomes
Companies that use Releaf
Customer profileSegments9 records
Ideal customer profiles7 records
Releaf technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration10 records
AI capability5 records
Feature4 records
Releaf partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered flagship, core and minor.
- Irwin MitchellflagshipReleaf has partnered with UK law firm Irwin Mitchell to launch "Releaf Protect," a 24/7 legal support service for medical cannabis patients. The service helps patients who face employment discrimination, police interaction issues or other legal challenges after disclosing a medical cannabis prescription. Coverage in businessofcannabis (2026-03-06 and 2026-02-06) frames the partnership as a major patient-protection initiative and one of the most substantive service additions from a UK medical cannabis clinic.
- Grafenberger ApothekecoreLicensed German pharmacy at Grafenberger Allee 409, 40235 Düsseldorf, listed as a Releaf DE partner pharmacy on the contact page. Pharmacist-staffed dispensary that fulfills Releaf prescriptions, including specific product lines such as Pedanios 31/1 COS-CA Cosmic Cream. Patients with delivery questions are referred directly to the pharmacy (Phone: 0211 54239220, [email protected]).
- Apotheke am Bahnhof (Speyer)coreSecond German partner pharmacy disclosed on the Releaf DE contact page, located at Bahnhofstraße 49, 67346 Speyer. Fulfills Releaf prescriptions in the Speyer area (Phone: 06232 73132, [email protected]).
- Aurora (Aurora Cannabis Inc.)coreAurora supplies the Pedanios line of medical cannabis products distributed by Releaf DE, including strains like Pedanios 31/1 COS-CA Cosmic Cream, Pedanios 26/1 EHD-CA Electric Honeydew, and Pedanios 10/13 MBE-CA Moon Berry — cultivated in Canada under GMP/GCP conditions with irradiated post-harvest processing.
- CannamedicalcoreCannamedical is a major product supplier for Releaf DE, providing strains such as Cannamedical Sativa forte NM Wedding Tree, Cannamedical Hybrid Forte 24/1 Garlic Truffle, Cannamedical Hybrid Forte DK 24/1 Ghost Train Haze, and Cannamedical Hybrid Forte NM Gorilla Zkittlez — sourced from North Macedonia, Denmark and Canada.
- Dr. AnsayminorListed on Releaf DE's "Wir sind Marktführer" comparison table as a German cannabis competitor (RX fee €14.20, flower from €3.40/g). It is referenced in a competitive context, not as a partnership, so it is included for completeness as an ecosystem peer.
- BloomwellminorListed on Releaf DE's "Wir sind Marktführer" comparison table as a German cannabis competitor (RX fee €25.22, flower from €4.99/g). It is referenced in a competitive context, not as a partnership, so it is included for completeness as an ecosystem peer.
Scale indicators8 records
Recent moves7 records
Expansion highlights7 records
Releaf competitors and assessment
Company assessmentDirect peers
- Lyphe Clinic: UK private medical cannabis clinic offering online consultations, prescriptions and pharmacy fulfillment. Directly comparable to Releaf UK in patient base size, indication coverage and D2C digital clinic model.
- Mamedica: UK private medical cannabis clinic prescribing for chronic pain, mental health and neurological conditions via an online consultation model. Closely comparable patient journey, target indications and pricing structure to Releaf UK.
- The Medical Cannabis Clinics: One of the established UK private medical cannabis clinic networks with online consultations and home delivery. Operates in the same regulatory environment and patient segments as Releaf UK.
- CB1 Medical: UK-based medical cannabis clinic with a digital prescribing and pharmacy-fulfillment model targeting chronic pain, anxiety and sleep patients. Directly competes with Releaf for the same private UK patient base.
- Curaleaf Clinic (formerly Kanabo): UK medical cannabis clinic offering online specialist consultations and prescriptions, part of the wider Curaleaf group. Comparable digital clinic model and patient target audience to Releaf UK.
- Bloomwell: Germany-based medical cannabis telehealth platform explicitly benchmarked by Releaf on its own competitive comparison page. Closest direct peer in Germany for online prescriptions, pricing (€25.22 Rx fee) and flower selection.
- Dr. Ansay (Sanity Group): German online cannabis clinic operated by Sanity Group, explicitly listed by Releaf as a benchmark competitor (€14.20 Rx fee, flower from €3.40/g). Direct competitor in the German D2C medical cannabis clinic market.
Broad incumbents
- Cantourage: European medical cannabis distributor and platform that works with multiple clinics and pharmacies across Germany and the UK. Comparable in product breadth and pharma-grade supply chain, though it operates B2B rather than D2C.
- Zerenia Clinics: Multi-country medical cannabis clinic group (UK, Germany, Italy, Colombia) offering specialist consultations and prescriptions. Operates the same D2C clinic model as Releaf but with broader geographic footprint and incumbent scale.
Emerging players
- Sana Healthcare: UK emerging private medical cannabis clinic with a digital consultation workflow. Smaller patient base than Releaf but overlapping indications and target audience, positioning it as a UK emerging peer.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Releaf social profiles
Digital presenceReleaf compliance and trust
Trust signalCompliance3 records
Releaf financial estimates
Financial estimateRevenue estimate
Valuation estimate
Releaf leadership team
Management profileNumber of profiles
Profiles10 records
Releaf subsidiaries and ownership
Company hierarchySubsidiaries1 record
Releaf funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Releaf M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Releaf
What does Releaf do?
Releaf is a private medical cannabis clinic group operating in the UK and Germany that delivers online specialist consultations, physician-issued prescriptions, and direct-to-patient pharmacy fulfillment of 50+ medical cannabis flower strains via a proprietary digital health platform with AI-assisted strain matching. Patients complete a 15-question medical questionnaire (no video call required), receive a prescription (€5.99 flat fee in Germany) and have medication delivered same-day or next-day from licensed partner pharmacies, with the UK parent entity being Releaf Dispensary Ltd and the German subsidiary being Releaf DE GmbH.
Is Releaf a public or private company?
Releaf is a private company. It is classified as unknown and is currently operating.
When was Releaf founded?
Releaf was founded in 2022. It employs 101 to 250 people.
Where is Releaf based?
Releaf is headquartered in London, United Kingdom, in the Europe region.
How does Releaf make money?
Three revenue lines are on record. Prescription fee + product sales (Germany) is the primary driver. The others are direct medical cannabis e-commerce and private medical cannabis clinic services (UK).
Who are Releaf's main competitors?
Direct peers on record are Lyphe Clinic, Mamedica, The Medical Cannabis Clinics, CB1 Medical, Curaleaf Clinic (formerly Kanabo), Bloomwell and Dr. Ansay (Sanity Group). Broad incumbents are Cantourage and Zerenia Clinics. Sana Healthcare is listed as an emerging player.
Does Releaf have an API?
No public API is recorded for Releaf.
What industry is Releaf in?
Releaf's product category is Medical Cannabis Telehealth. Its primary akta.pro industry code is CRANAFAB, Medical Cannabis Dispensaries, with a secondary code of CRANAFAG, Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail). Its NAICS code is 6215 and its SIC code is 5912.